Application of chimeric antigen receptor-T cell therapy in hematological diseases: reports from the 57th American Society of Hematology annual meeting / 白血病·淋巴瘤

ABSTRACT

Chimeric antigen receptor-T cell (CAR-T) therapy is one of the effective novel immunotherapy for malignancies, and it has a great effect on leukemia and lymphoma. More researches are needed to improve the understanding of CAR-T therapy and promote the development of this technology in order to treat hematological malignancies from a novel perspective.